Back
AVITA Medical Vs. Perspective Therapeutics Industry Stock Comparison
Sell
42
RCEL
AVITA Medical
Last Price:
8.21
Seasonality Move:
2.07%
Buy
56
CATX
Perspective Therapeutics
Last Price:
1.55
Seasonality Move:
2.9%
Sell
42
AVITA Medical (RCEL)
is a Sell
Is AVITA Medical a Buy, Sell or Hold?
- The current AVITA Medical [RCEL] share price is $8.17. The Score for RCEL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.63. The Score for CATX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCEL Stock Price Chart
What is AVITA Medical's stock price today?
-
The AVITA Medical share price today is $8.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCEL is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.63
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
RCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 34.42 | Sell |
| Chaikin Money Flow: | -61877 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.26 - 9.06) | Sell |
| Bollinger Bands (100): | (10.49 - 17.45) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 51.22 | Buy |
| Chaikin Money Flow: | 780415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.77) | Sell |
| Bollinger Bands (100): | (0.68 - 1.54) | Buy |
RCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.33 | Sell |
| 20-day SMA: | 8.57 | Sell |
| 50-day SMA: | 11.9 | Sell |
| 200-day SMA: | 13.6 | Sell |
| 8-day EMA: | 8.34 | Sell |
| 20-day EMA: | 8.97 | Sell |
| 50-day EMA: | 11.03 | Sell |
| 200-day EMA: | 13.11 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.67 | Sell |
| 20-day SMA: | 1.7 | Sell |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 0.71 | Buy |
| 8-day EMA: | 1.65 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.47 | Buy |
| 200-day EMA: | 0.92 | Buy |
AVITA Medical Earnings Growth & RCEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.25 per share, and an increase next year of $0.98 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AVITA Medical Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||